Consolidated Balance Sheets (USD $)
In Millions, unless otherwise specified
Dec. 31, 2014
Dec. 31, 2013
Current assets    
Cash and cash equivalents (including restricted cash of $16 and $14, respectively) $ 172 $ 393
Short-term investments 7 7
Accounts receivable (net of allowance for doubtful accounts of $14 and $16, respectively) 591 601
Inventories:    
Finished and in-process goods 288 257
Raw materials and supplies 110 103
Other current assets 73 72
Total current assets 1,241 1,433
Investments in unconsolidated entities 48 45
Deferred Income Taxes 18 21
Other assets, net 110 134
Property and equipment    
Land 89 88
Buildings 302 308
Machinery and equipment 2,419 2,427
Property, plant and equipment, gross 2,810 2,823
Less accumulated depreciation (1,755) (1,776)
Property, plant and equipment, net 1,055 1,047
Goodwill 119 112
Other intangible assets, net 81 82
Total assets 2,672 2,874
Current liabilities    
Accounts and drafts payable 426 483
Debt payable within one year 99 109
Interest payable 82 83
Income taxes payable 12 12
Accrued payroll and incentive compensation 67 47
Other current liabilities 135 127
Total current liabilities 821 861
Long-term liabilities    
Long-term debt 3,735 3,665
Long-term pension and post employment benefit obligations 278 234
Long-term deferred income taxes 19 21
Other long-term liabilities 171 163
Total liabilities 5,024 4,944
Deficit    
Common stock—$0.01 par value; 300,000,000 shares authorized, 170,605,906 issued and 82,556,847 outstanding at December 31, 2014 and 2013 1 1
Paid-in capital 526 522
Treasury stock, at cost—88,049,059 shares (296) (296)
Accumulated other comprehensive income (159) (21)
Accumulated deficit (2,423) (2,275)
Total Momentive Specialty Chemicals Inc. shareholder’s deficit (2,351) (2,069)
Noncontrolling interest (1) (1)
Total deficit (2,352) (2,070)
Total liabilities and deficit $ 2,672 $ 2,874